![Colleen Sjogren](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Colleen Sjogren
Corporate Officer/Principal at
NUVATION BIO INC.
Net worth: 559 440 $ as of 31/08/2026
Profile
Ms. Colleen Sjogren is a Chief Commercial Officer at Nuvation Bio, Inc. Ms. Sjogren was previously employed as a Senior Vice President-Sales by Madrigal Pharmaceuticals, Inc., a VP-US Sales, Sales Training & Meeting Planning by Mirati Therapeutics, Inc., and a Vice President-National Cell Therapy & Sales by Kite Pharma, Inc. She received her undergraduate degree from Bryant University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 27/02/2026 | 84,000 ( 0.02% ) | 559 440 $ | 31/08/2026 |
Colleen Sjogren active positions
| Companies | Position | Start |
|---|---|---|
| NUVATION BIO INC. | Corporate Officer/Principal | 28/03/2024 |
Former positions of Colleen Sjogren
| Companies | Position | End |
|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. | Sales & Marketing | 01/12/2023 |
| MIRATI THERAPEUTICS | Sales & Marketing | 01/09/2022 |
| KITE PHARMA INC | Sales & Marketing | 01/04/2021 |
Training of Colleen Sjogren
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
70
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
Bryant University
 Bryant University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kite Pharma, Inc.
 Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
Madrigal Pharmaceuticals, Inc.
 Madrigal Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs for cardiovascular, metabolic and liver diseases | Health Technology |
Nuvation Bio, Inc.
 Nuvation Bio, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops oncology related novel therapeutic candidates | Health Technology |
- Stock Market
- Insiders
- Colleen Sjogren
